Beta Cat Pharmaceuticals
Beta Cat Pharmaceuticals is developing compounds which modulate beta catenin and are in the translational phase. These compounds target beta catenin, the end result of seminal mutations in the APC/WNT pathway, and modulate it by degrading it in the cytoplasm, and denying it access to the nucleus, where it is believed to be highly oncologic and drive cancer growth as a cancer stem cell pathway.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Beta Cat Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Beta Cat Pharmaceuticals
1 distinct titles indexed · top 1 shown.
- 1owner
Sign up to unlock all 1 contacts at Beta Cat Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Beta Cat Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.